Citius Pharmaceuticals, Inc. Payments for Repurchase of Preferred Stock and Preference Stock
Citius Pharmaceuticals, Inc. (CTXR) reported Payments for Repurchase of Preferred Stock and Preference Stock of $100 for the 9-month period ending 2025-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsForRepurchaseOfPreferredStockAndPreferenceStock · last filed 2026-08-14
- 2025-06-30: Payments for Repurchase of Preferred Stock and Preference Stock 9 month $100.00.
| Period end | Payments for Repurchase of Preferred Stock and Preference Stock 9 month |
|---|---|
| 2025-06-30 | $100.00 10-Q · filed 2026-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |